Observational study / 2023
Childhood exposure to glyphosate degradation product AMPA and nearby agricultural glyphosate use were linked to metabolic syndrome and elevated transaminases at age 18.
Researchers examined urinary glyphosate and AMPA, as well as residential proximity to agricultural glyphosate applications, across childhood up to age 18 years in the CHAMACOS study. Urinary AMPA at age 5 years was associated with elevated transaminases (RR per 2-fold increase = 1.27, 95% CI: 1.06, 1.53) and metabolic syndrome (RR = 2.07, 95% CI: 1.38, 3.11). At age 14 years, urinary AMPA (RR = 1.80, 95% CI: 1.10, 2.93) and glyphosate residues (RR = 1.88, 95% CI: 1.03, 3.42) were associated with metabolic syndrome. Overall, a 2-fold increase in childhood urinary AMPA was linked to 14% and 55% higher risks of elevated transaminases and metabolic syndrome, respectively, while nearby agricultural applications from birth to age 5 were also linked to metabolic syndrome (RR = 1.53, 95% CI: 1.16, 2.02).
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort and nested case-control study
- Who was studied
- 480 mother-child dyads (cohort) and 60 cases with elevated transaminases vs 91 controls from the CHAMACOS study
- What was measured
- Elevated liver transaminases and metabolic syndrome at age 18 years
THE PAPER
Association of Lifetime Exposure to Glyphosate and Aminomethylphosphonic Acid (AMPA) with Liver Inflammation and Metabolic Syndrome at Young Adulthood: Findings from the CHAMACOS Study.
Eskenazi B, Gunier RB, Rauch S, Kogut K, Perito ER, Mendez X, Limbach C, Holland N, Bradman A, Harley KG, Mills PJ, Mora AM. Environ Health Perspect, 2023.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.